Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders

NCT05792540 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder

Interventions

DRUG: Fluoxetine 20 mg
DRUG: Dapagliflozin 10mg Tab
DRUG: Atorvastatin 80mg

Sponsor

Tanta University

Collaborators

[object Object]